Literature DB >> 24405418

A mouse bone marrow stromal cell line with skeletal stem cell characteristics to study osteogenesis in vitro and in vivo.

Sebastian Raeth1, Benedetto Sacchetti, Georg Siegel, Ulrike A Mau-Holzmann, Jan Hansmann, Gabriele Vacun, Thomas G Hauk, Klaus Pfizenmaier, Angelika Hausser.   

Abstract

Bone marrow stromal cells (BMSCs) are composed of progenitor and multipotent skeletal stem cells, which are able to differentiate in vitro into osteocytes, adipocytes, and chondrocytes. Mouse BMSCs (mBMSCs) are a versatile model system to investigate factors involved in BMSC differentiation in vitro and in vivo as a variety of transgenic mouse models are available. In this study, mBMSCs were isolated and osteogenic differentiation was investigated in tissue culture and in vivo. Three out of seven independent cell isolates showed the ability to differentiate into osteocytes, adipocytes, and chondrocytes in vitro. In vitro multipotency of an established mBMSC line was maintained over 45 passages. The osteogenic differentiation of this cell line was confirmed by quantitative polymerase chain reaction (qPCR) analysis of specific markers such as osteocalcin and shown to be Runx2 dependent. Notably, the cell line, when transplanted subcutaneously into mice, possesses full skeletal stem cell characteristics in vivo in early and late passages, evident from bone tissue formation, induction of vascularization, and hematopoiesis. This cell line provides, thus, a versatile tool to unravel the molecular mechanisms governing osteogenesis in vivo thereby aiding to improve current strategies in bone regenerative therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24405418     DOI: 10.1089/scd.2013.0367

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  7 in total

Review 1.  Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency.

Authors:  Mara Ulin; Esra Cetin; Elie Hobeika; Rishi Man Chugh; Hang-Soo Park; Sahar Esfandyari; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2021-05-06       Impact factor: 3.060

2.  A perfusion bioreactor system efficiently generates cell-loaded bone substitute materials for addressing critical size bone defects.

Authors:  Claudia Kleinhans; Ramkumar Ramani Mohan; Gabriele Vacun; Thomas Schwarz; Barbara Haller; Yang Sun; Alexander Kahlig; Petra Kluger; Anna Finne-Wistrand; Heike Walles; Jan Hansmann
Journal:  Biotechnol J       Date:  2015-06-24       Impact factor: 4.677

3.  Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein.

Authors:  Irene Marini; Martin Siegemund; Meike Hutt; Roland E Kontermann; Klaus Pfizenmaier
Journal:  Front Immunol       Date:  2017-05-11       Impact factor: 7.561

4.  miR-200a contributes to the migration of BMSCs induced by the secretions of E. faecalis via FOXJ1/NFκB/MMPs axis.

Authors:  Mingwei Li; Lifan Wei; Wei Zhou; Zhiyan He; Shujun Ran; Jingping Liang
Journal:  Stem Cell Res Ther       Date:  2020-07-25       Impact factor: 6.832

5.  Combined Use of Autologous Bone Marrow-derived Stem Cells and Platelet-rich Plasma for Ovarian Rejuvenation in Poor Responders.

Authors:  Sunita Tandulwadkar; M Selva Karthick
Journal:  J Hum Reprod Sci       Date:  2020-10-27

6.  The New Role of CD163 in the Differentiation of Bone Marrow Stromal Cells into Vascular Endothelial-Like Cells.

Authors:  Wei Lu; Le Su; Zhezheng Yu; Shangli Zhang; Junying Miao
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

Review 7.  The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure.

Authors:  Yantao He; Dongmei Chen; Lingling Yang; Qiaoni Hou; Huiming Ma; Xian Xu
Journal:  Stem Cell Res Ther       Date:  2018-10-04       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.